Details for Patent: 11,103,669
✉ Email this page to a colleague
Which drugs does patent 11,103,669 protect, and when does it expire?
Patent 11,103,669 protects GENOSYL and is included in one NDA.
This patent has six patent family members in five countries.
Summary for Patent: 11,103,669
Title: | Nitric oxide therapies |
Abstract: | A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition. |
Inventor(s): | Fine; David H. (Cocoa Beach, FL) |
Assignee: | Vero Biotech LLC (Atlanta, GA) |
Application Number: | 14/948,992 |
Patent Claim Types: see list of patent claims | Device; |
Drugs Protected by US Patent 11,103,669
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,103,669
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010263098 | ⤷ Try a Trial | |||
Canada | 2763804 | ⤷ Try a Trial | |||
European Patent Office | 2445508 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |